Trump slams drug companies for raising prices

Image
Press Trust of India Washington
Last Updated : Jul 10 2018 | 1:15 AM IST

US President Donald Trump today slammed Pfizer and other pharma companies for raising prices of drugs and said that they should be ashamed of it.

Pfizer & others should be ashamed that they have raised drug prices for no reason, Trump said in a tweet, days after major pharmaceutical companies raised prices of some drugs.

They (pharma companies) are merely taking advantage of the poor and others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe & elsewhere, he said.

Trump warned that his administration would respond to such an unjustified increase in drug prices.

On July 1, Pfizer increased the prices of over 40 drugs including Viagra. Pfizer was followed by other pharma companies.

Our portfolio includes more than 400 medicines and vaccines; we are modifying prices for approximately 10 per cent of these, including some instances where we're decreasing the price," Pfizer said in a statement.

The list prices don't reflect what most patients or insurance companies pay due to rebates to payers and others in the supply chain, Pfizer said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 10 2018 | 1:15 AM IST

Next Story